Heliad AG
ISIN: DE0001218063
WKN: 121806
15 January 2025 10:23AM

EQS-News: Heliad: Nelly raises EUR 50m in Series B funding to revolutionize financial operations in healthcare

Heliad AG · ISIN: DE0001218063 · EQS - Company News
Country: Germany · Primary market: Germany · EQS NID: 2068341

EQS-News: Heliad AG / Key word(s): Investment
Heliad: Nelly raises EUR 50m in Series B funding to revolutionize financial operations in healthcare

15.01.2025 / 10:23 CET/CEST
The issuer is solely responsible for the content of this announcement.


Berlin, January 15, 2025 – Nelly Solutions, one of Europe’s fastest-growing health and fintech companies, has successfully closed a €50 million Series B funding round. This capital will accelerate the company’s mission to digitalize the European healthcare sector and make administrative and financial processes in medical facilities significantly more efficient. The round was led by Cathay Innovation, joined by Notion Capital, and existing investors b2venture, Lakestar, Motive Ventures, arc investors – as well as Heliad, which has been invested in Nelly since December 2022 through its newly integrated early-stage strategy Collective Ventures.

The funding reflects the potential of Nelly’s innovative platform, which is already used by over 1,200 medical practices and provides patients with a fully digital, seamless experience – from check-in to payment. The company aims to use this capital to further develop its products, expand geographically, and strengthen its market leadership in Germany.

Urgent Need for Digitalization in Healthcare

According to a 2024 survey by the German Health IT Association (bvitg), the adoption of digital solutions in medical practices and hospitals could save up to €6.4 billion annually. The greatest potential for savings lies in administration and billing, where efficient digital processes can reduce costs by up to 30%. Nelly addresses these challenges with its Financial Operating System (FinOS) and Patient Experience Platform, which streamline workflows such as patient intake, document management, and payment processing. By integrating with practice management systems, the platform saves time and resources for both healthcare providers and patients.

Focus on Expansion and Product Development

Since its previous funding round, Nelly has more than doubled its customer base and now digitalizes processes for over 2 million patients. The new capital will be used to further develop its product portfolio and expand into new European markets. Recently, Nelly entered the Italian market, which faces similar structural challenges in healthcare administration.

“The support of our investors not only reflects their confidence in our team and business model but also in our ability to improve efficiencies in healthcare and provide patients with a better experience,” said Niklas Radner, co-founder and CEO of Nelly. “Our goal is to minimize administrative burdens and become the largest fintech platform in healthcare.”

Jacky Abitbol, Managing Partner at Cathay Innovation, said: “Improving efficiency in healthcare is one of our core investment theses. Nelly has the potential to become the leading financial platform for medical practices in Europe. We are excited to support their international expansion.”

Itxaso del Palacio, General Partner at Notion Capital, added: “Nelly uniquely combines software and fintech expertise and is excellently positioned to become a market leader in this space. We are proud to be part of this journey.”

About Nelly Solutions

Nelly revolutionizes the experience for patients and medical professionals by automating administrative processes and cashflows in healthcare. Founded in 2021 by Niklas Radner, Lukas Eicher, Rasmus Schults, and Laurids Seibel, the Berlin-based startup aims to minimize the administrative burden for doctors, medical staff, and patients. As the first digital factoring provider in the DACH region, Nelly offers a comprehensive solution that not only enables the digitalization of patient data but also automates receivable management for medical practices. The platform provides a fully GDPR-compliant digital process, from patient intake to payment with a single click. Seamless integration with existing practice management software and user-friendly operation allow patients to securely and efficiently manage everything via their smartphone. Nelly has already digitized 30 million paper documents and digitally processed over 2 million patients, saving an average of 10 minutes per patient. This translates into hundreds of thousands of hours saved in the healthcare sector. For more information, visit https://www.getnelly.de/.

About Heliad
Heliad (Stock ticker A7A, ISIN DE0001218063) is a listed investment company with a mission to empower both entrepreneurs and investors. The company invests in market leading companies across various verticals and regions to power their next phase of growth. As a listed company and through our strong team and strategic partners, Heliad can support companies pre, at and post IPO and act as a gateway to public equity capital markets. An evergreen structure positions Heliad to act independently of usual fund lifecycles, while providing shareholders with proprietary access to pre-IPO market returns without limitations on investment size or terms. For more information about Heliad, please visit www.heliad.com and follow on LinkedIn to stay updated.

Contact
Heliad AG
Tel: +49 69 719 12 80 00
E-Mail: investor-relations@heliad.com


15.01.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Heliad AG
Ulmenstraße 37-39
60325 Frankfurt/Main
Germany
Phone: +49 (0)69 719 12 80 - 00
Fax: +49 (0)69 719 12 80 - 999
E-mail: investor-relations@heliad.com
Internet: www.heliad.com
ISIN: DE0001218063
WKN: 121806
Indices: Basic Board
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2068341

 
End of News EQS News Service

2068341  15.01.2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2068341&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2019 2020 2021 2022 2023 2024 2025e
Sales1 1,44 1,54 4,87 1,93 5,60 6,66 0,00
EBITDA1,2 10,15 3,01 2,70 4,84 21,31 31,49 0,00
EBITDA-Margin3 704,86 195,46 55,44 250,78 380,54 472,82 0,00
EBIT1,4 2,19 0,25 -0,70 2,37 21,14 31,32 0,00
EBIT-Margin5 152,08 16,23 -14,37 122,80 377,50 470,27 0,00
Net Profit (Loss)1 39,53 6,10 -0,35 2,04 20,13 30,57 0,00
Net-Margin6 2.745,14 396,10 -7,19 105,70 359,46 459,01 0,00
Cashflow1,7 1,42 2,26 -0,35 2,07 0,72 -2,02 0,00
Earnings per share8 7,33 1,11 -0,06 0,38 3,21 3,63 1,19
Dividend per share8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: Schneider + Partner

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Heliad
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
121806 DE0001218063 AG 129,77 Mio € 07.02.2007 Kaufen 9F2C4M88+75
* * *
PE 2026e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
11,34 9,10 1,25 5,59 0,57 -64,12 19,48
Dividends
Dividend '2023
in €
Dividend '2024
in €
Dividend '2025e
in €
Div.-Yield '2025e
in %
0,00 0,00 0,00 0,00%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
05.05.2025 30.09.2025 21.03.2025
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
+0,70%
14,40 €
ATH 62,22 €
-5,81% +0,43% +44,72% +37,14% -49,47%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL